Webinars and Events

Date Event and Location
February 19-24, 2017
Trade Show - San Francisco, CA

Molecular Med Tri-Conference is a premiere event for drug discovery, genomics, diagnostics and information technology. Visit us at booth 409!
March 1, 2017
Live Webinar Presented by XTalks

In this presentation, Dr. Sandi Deans of the UK National External Quality Assessment Service (UK NEQAS) will discuss a case study of how a global external quality assessment (EQA) organization is using these reference materials to ensure the accuracy and consistency of one such clinical genomics application in the area of non-invasive prenatal testing (NIPT).
March 30, 2017
Live Webinar Presented by GenomeWeb

The series will kick off at 11 am ET on March 30 with a roundtable of expert panelists who will provide an overview of the current regulatory landscape for laboratory-developed tests, particularly in light of the FDA's recent decision to delay finalizing its proposed guidance on the issue. Our panelists will discuss how clinical genomics labs can and should ensure the analytical and clinical validity of their tests amid an uncertain regulatory climate. Webinar attendees will be able to ask questions of our panelists during a live Q&A session.
April 13, 2017
Live Webinar Presented by GenomeWeb

In this webinar case study, Gregory J. Tsongalis of Dartmouth Hitchcock Medical Center will discuss how his lab developed and validated a cancer hotspot assay. Webinar attendees will be able to ask questions during a live Q&A session.
April 27, 2017
Live Webinar Presented by GenomeWeb

In this webinar case study, Robert Daber, formerly of BioReference Laboratory, will discuss how labs can establish laboratory QC systems to comply with CAP, CLIA, and state regulatory guidelines. Webinar attendees will be able to ask questions during a live Q&A session.
May 9, 2017
Live Webinar Presented by GenomeWeb

In this webinar case study, Tony Godfrey of the Boston University School of Medicine will discuss how his lab is developing and validating clinical circulating tumor DNA assays. Webinar attendees will be able to ask questions during a live Q&A session.